Serial intraarticular injections of growth factor concentrate in knee osteoarthritis: A placebo controlled randomized study
In brief
In this triple-blinded, placebo-controlled randomised study, people with moderate knee osteoarthritis received a monthly series of growth factor concentrate (GFC) or saline injections. Both groups improved, but the authors report clearly better pain and function with GFC for up to a year, along with a fall in a blood marker of cartilage breakdown.
Read the original paper (opens in a new tab)
Citation, as listed in the PRP guidelines
Serial intraarticular injections of growth factor concentrate in knee osteoarthritis: A placebo controlled randomized study Authors: Amit Saraf, Altaf Hussain, Sandeep Bishnoi, Hamza Habib, Abhishek Garg Link: https://pubmed.ncbi.nlm.nih.gov/36974096/ Year of Publication: 2023
A summary of published research for general information. It does not replace a consultation; whether a treatment suits you is decided by a specialist after examination.
More from the PRP guidelines
- Autologous Peripheral Blood-Derived Orthobiologics for the Management of Elbow Disorders: A Review of Current Clinical Evidence2025
- Intra-articular injections of hyaluronic acid versus plasma rich in growth factors (PRGF) for knee osteoarthritis: a meta-analysis of randomised controlled trials2025
- Comparison of Platelet-Rich Plasma and Corticosteroid Injections for Chronic Plantar Fasciitis: A Randomized Controlled Trial2024
- The Safety and Effectiveness of Orthobiologic Injections for Discogenic Chronic Low Back Pain: A Multicenter Prospective, Crossover, Randomized Controlled Trial with 12 Months Follow-up2024

